This white paper provides a comprehensive overview of the global stroke treatment pipeline and clinical trial landscape using IQVIA Pipeline Link and Trial Link data. It reviews current limitations of stroke care, including narrow treatment windows and limited neurorecovery, and highlights emerging therapeutic strategies targeting neuroprotection, regeneration, and extended intervention windows. The analysis identifies 77 active pipeline programs, dominated by small molecules and stem cell therapies, with increasing focus on precision targets and multimodal mechanisms. Late-stage candidates aim to improve functional recovery and reduce complications, while early-stage innovations explore novel molecular and cellular approaches. The paper concludes that strong pipeline momentum signals rene

Join for free to read